View Filing Data

Document and Entity Information - shares	6 Months Ended
Document and Entity Information - shares	Jun. 30, 2013	Jul. 31, 2013
Document and Entity Information [Abstract]
Entity Registrant Name	AMN HEALTHCARE SERVICES INC
Entity Central Index Key	0001142750
Document Type	10-Q
Document Period End Date	Jun. 30, 2013
Amendment Flag	false
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q2
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		45,961,566

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2013	Dec. 31, 2012
Current assets:
Cash and cash equivalents	$ 10,519	$ 5,681
Accounts receivable, net of allowances of $4,338 and $5,003 at June 30, 2013 and December 31, 2012, respectively	149,798	142,510
Accounts receivable, subcontractor	15,728	18,467
Deferred income taxes, net	18,683	18,123
Prepaid and other current assets	15,502	18,963
Total current assets	210,230	203,744
Restricted cash, cash equivalents and investments	20,960	18,861
Fixed assets, net	16,826	14,815
Deposits and other assets	22,536	19,732
Goodwill	123,324	123,324
Intangible assets, net	133,708	136,910
Total assets	527,584	517,386
Current liabilities:
Accounts payable and accrued expenses	52,374	52,619
Accrued compensation and benefits	46,871	49,443
Current portion of notes payable	5,000	0
Other current liabilities	6,924	7,463
Total current liabilities	111,169	109,525
Notes payable, less current portion and discount	148,524	158,178
Other long-term liabilities	69,967	67,572
Total liabilities	329,660	335,275
Commitments and contingencies (Note 9)
Stockholders’ equity:
Preferred stock, $0.01 par value; 10,000 shares authorized (including 5,941 shares of series A conditional convertible preferred stock); none issued and outstanding at June 30, 2013 and December 31, 2012	0	0
Common stock, $0.01 par value; 200,000 shares authorized; 46,166 shares issued and 45,962 shares outstanding at June 30, 2013; 45,691 shares issued and outstanding at December 31, 2012	462	457
Additional paid-in capital	427,119	424,292
Treasury stock, at cost (204 and 0 shares at June 30, 2013 and December 31, 2012, respectively)	(3,046)	0
Accumulated deficit	(226,233)	(242,195)
Accumulated other comprehensive loss	(378)	(443)
Total stockholders’ equity	197,924	182,111
Total liabilities and stockholders’ equity	$ 527,584	$ 517,386

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) shares in Thousands, $ in Thousands	Jun. 30, 2013	Dec. 31, 2012
Accounts receivable, allowance	$ 4,338	$ 5,003
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	10,000	10,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Series A conditional convertible preferred stock, shares authorized	5,941	5,941
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	200,000	200,000
Common stock, shares issued	46,166	45,691
Common stock, shares outstanding	45,962	45,691
Treasury stock, shares	204	0

Condensed Consolidated Statements of Comprehensive Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Revenue	$ 253,943	$ 235,786	$ 506,063	$ 462,198
Cost of revenue	179,530	168,813	358,643	332,011
Gross profit	74,413	66,973	147,420	130,187
Operating expenses:
Selling, general and administrative	54,551	50,304	108,158	97,480
Depreciation and amortization	3,240	3,552	6,530	7,247
Total operating expenses	57,791	53,856	114,688	104,727
Income from operations	16,622	13,117	32,732	25,460
Interest expense, net	3,130	13,590	5,989	19,123
Income (loss) from continuing operations before income taxes	13,492	(473)	26,743	6,337
Income tax expense (benefit)	5,093	(392)	10,781	2,965
Income (loss) from continuing operations	8,399	(81)	15,962	3,372
Income from discontinued operations, net of tax	0	0	0	823
Net income (loss)	$ 8,399	$ (81)	$ 15,962	$ 4,195
Basic income (loss) per common share from:
Continuing operations (in dollars per share)	$ 0.18	$ 0.00	$ 0.35	$ 0.07
Discontinued operations (in dollars per share)	0.00	0.00	0.00	0.02
Net income (in dollars per share)	0.18	0.00	0.35	0.09
Diluted income (loss) per common share from:
Continuing operations (in dollars per share)	0.18	0.00	0.33	0.07
Discontinued operations (in dollars per share)	0.00	0.00	0.00	0.02
Net income (in dollars per share)	$ 0.18	$ 0.00	$ 0.33	$ 0.09
Weighted average common shares outstanding:
Basic (shares)	46,039	40,810	45,927	40,695
Diluted (shares)	47,837	40,810	47,759	46,317
Other comprehensive income (loss) - foreign currency translation	$ (28)	$ 33	$ 65	$ (10)
Comprehensive income (loss)	$ 8,371	$ (48)	$ 16,027	$ 4,185

Condensed Consolidated Statement of Stockholders' Equity - 6 months ended Jun. 30, 2013 - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Treasury Stock [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Income (Loss) [Member]
Balance at Dec. 31, 2012	$ 182,111	$ 457	$ 424,292	$ 0	$ (242,195)	$ (443)
Balance, Shares at Dec. 31, 2012		45,691
Statement of Stockholders' Equity [Roll Forward]
Treasury Stock, Value, Acquired, Cost Method	(3,046)			(3,046)
Equity awards vested and issued and exercised, share		475
Equity awards vested and issued and exercised, value	(1,770)	$ 5	(1,775)
Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation	1,422		1,422
Stock-based compensation	3,180		3,180
Comprehensive income (loss)	16,027				15,962	65
Balance at Jun. 30, 2013	$ 197,924	$ 462	$ 427,119	$ (3,046)	$ (226,233)	$ (378)
Balance, Shares at Jun. 30, 2013		46,166

- Definition

This element represents the amount of recognized equity-based compensation during the period, that is, the amount recognized as expense in the income statement (or as asset if compensation is capitalized). Alternate captions include the words "stock-based compensation".

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 35
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415241&loc=d3e4534-113899

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 20
-Section 55
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6576910&loc=d3e11149-113907

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 20
-Section 55
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=6576910&loc=d3e11178-113907

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 123R
-Paragraph 64
-Subparagraph b
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 123R
-Paragraph A91
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 123R
-Paragraph 39
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

The change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to the reporting entity. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, but excludes any and all transactions which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent.

+ References + Details

- Definition

Number of shares (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of any shares forfeited. Shares issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.

+ References + Details

- Definition

Value of stock (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of stock value of such awards forfeited. Stock issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.

+ References + Details

- Definition

Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.

+ References + Details

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Cash flows from operating activities:
Net income	$ 15,962	$ 4,195
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	6,530	7,247
Non-cash interest expense	1,110	1,545
Loss on debt extinguishment	0	9,815
Increase in allowances for doubtful accounts and sales credits	1,648	3,453
Provision for deferred income taxes	862	1,327
Share-based compensation	3,180	3,009
Excess tax benefits from share-based compensation	(1,431)	(11)
Holdback settlement in equity from prior acquisition	(3,046)	0
Gain on sale of discontinued operations	0	(1,187)
Loss on disposal or sale of fixed assets	8	14
Changes in assets and liabilities, net of effects from divestiture:
Accounts receivable, net	(8,936)	6,666
Accounts receivable, subcontractor	2,739	501
Prepaid expenses and other current assets	3,461	(3,020)
Deposits and other assets	(3,056)	(857)
Accounts payable and accrued expenses	327	925
Accrued compensation and benefits	(2,572)	(626)
Other liabilities	1,886	(2,446)
Restricted cash, cash equivalents and investments balance	(2,150)	0
Net cash provided by operating activities	16,522	30,550
Cash flows from investing activities:
Purchase and development of fixed assets	(5,348)	(2,210)
Proceeds from sales of assets held for sale	0	8,622
Change in restricted cash, cash equivalents and investments balance	51	(91)
Net cash (used in) provided by investing activities	(5,297)	6,321
Cash flows from financing activities:
Capital lease repayments	(318)	(330)
Proceeds from revolving credit facility	1,000	0
Payments on revolving credit facility	(1,000)	(3,000)
Repayments of prior notes payable	0	(206,500)
Payments on term loan credit facility	(5,000)	(4,380)
Proceeds from term loan credit facility, net of discount	0	198,000
Payment of financing costs	(935)	(3,898)
Prepayment penalty associated with the prior credit facilities	0	(1,200)
Proceeds from exercise of equity awards	767	0
Cash paid for shares withheld for taxes	(2,537)	(843)
Excess tax benefits from share-based compensation	1,431	11
Change in bank overdraft	140	(3,185)
Net cash used in financing activities	(6,452)	(25,325)
Effect of exchange rate changes on cash	65	(10)
Net increase in cash and cash equivalents	4,838	11,536
Cash and cash equivalents at beginning of period	5,681	3,962
Cash and cash equivalents at end of period	10,519	15,498
Supplemental disclosures of cash flow information:
Cash paid for interest (net of $43 and $20 capitalized for the six months ended June 30, 2013 and 2012, respectively)	4,233	8,067
Cash paid for income taxes	$ 9,345	$ 314

Condensed Consolidated Statements of Cash Flows (Parenthetical) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Interest capitalized	$ 43	$ 20

Basis of Presentation	6 Months Ended
Basis of Presentation	Jun. 30, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION	BASIS OF PRESENTATION The condensed consolidated balance sheets and related condensed consolidated statements of comprehensive income (loss), stockholders’ equity and cash flows contained in this Quarterly Report on Form 10-Q (this “Quarterly Report”), which are unaudited, include the accounts of AMN Healthcare Services, Inc. and its wholly-owned subsidiaries (collectively, the “Company”). All significant intercompany balances and transactions have been eliminated in consolidation. In the opinion of management, all entries necessary for a fair presentation of such unaudited condensed consolidated financial statements have been included. These entries consisted only of normal recurring items. The results of operations for the interim period are not necessarily indicative of the results to be expected for any other interim period or for the entire fiscal year or for any future period. The unaudited condensed consolidated financial statements do not include all information and notes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States. Please refer to the Company’s audited consolidated financial statements and the related notes for the fiscal year ended December 31, 2012, contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2012, filed with the Securities and Exchange Commission (“SEC”) on February 22, 2013. The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to asset impairments, accruals for self-insurance, compensation and related benefits, accounts receivable, contingencies and litigation, valuation and recognition of share-based payments and income taxes. Actual results could differ from those estimates under different assumptions or conditions. Certain amounts in the unaudited condensed consolidated financial statements for the three and six months ended June 30, 2012 have been reclassified to conform to the three and six months ended June 30, 2013 presentation. Recently Adopted Accounting Pronouncements In July 2012, the Financial Accounting Standards Board issued an accounting standard update intended to simplify how an entity tests indefinite-lived intangible assets other than goodwill for impairment by providing entities with an option to perform a qualitative assessment to determine whether further impairment testing is necessary. This accounting standard update is effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012. The Company adopted this guidance effective January 1, 2013 and such adoption did not have a material effect on its unaudited condensed consolidated financial statements.

Discontinued Operations

6 Months Ended

Jun. 30, 2013

Discontinued Operations and Disposal Groups [Abstract]

DISCONTINUED OPERATIONS

In January 2012, the Company completed the sale of its home healthcare services segment and the related results of operations have been classified as discontinued operations for the six months ended June 30, 2012. The following table represents the revenue and the components of discontinued operations, net of tax:



	Six months ended June 30, 2012
Revenue	$	3,885

Loss before income taxes	(547		)
Income tax benefit	183
Loss from discontinued operations	(364		)

Gain on sale of discontinued operations, before income taxes	3,825
Income tax expense	(2,638		)
Gain on sale of discontinued operations	1,187

Total income from discontinued operations	$	823

- Definition

The entire disclosure for the facts and circumstances leading to the completed or expected disposal, manner and timing of disposal, the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and pretax profit or loss reported in discontinued operations, the segment in which the disposal group was reported, and the classification (whether sold or classified as held for sale) and carrying value of the assets and liabilities comprising the disposal group. Includes all disposal groups, including those classified as components of the entity (discontinued operations).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1436-107760

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1510-107760

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1474-107760

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1020-107759

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1012-107759

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=8077374&loc=d3e2443-110228

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6391110&loc=d3e2941-110230

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 144
-Paragraph 43-48
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Revenue Recognition	6 Months Ended
Revenue Recognition	Jun. 30, 2013
Revenue Recognition [Abstract]
REVENUE RECOGNITION	REVENUE RECOGNITION Revenue consists of fees earned from the permanent and temporary placement of clinicians and physicians. Revenue is recognized when earned and realizable. The Company has entered into certain contracts with healthcare organizations to provide managed services programs. Under these contract arrangements, the Company uses its clinicians and physicians along with those of third party subcontractors to fulfill client orders. If the Company uses subcontractors, it records revenue net of related subcontractors expense. The resulting net revenue represents the administrative fee the Company charges for its vendor management services. The Company records subcontractor accounts receivable from the client in the consolidated balance sheets. The Company generally pays the subcontractor after it has received payment from the client. Payables to subcontractors of $14,909 and $18,129, respectively, were included in accounts payable and accrued expenses in the unaudited condensed consolidated balance sheet as of June 30, 2013 and consolidated balance sheet as of December 31, 2012.

Net Income (Loss) Per Common Share

6 Months Ended

Jun. 30, 2013

Earnings Per Share [Abstract]

NET INCOME (LOSS) PER COMMON SHARE

Securities that are entitled to participate in dividends with common stock, such as the Company’s Series A Conditional Convertible Preferred Stock (the “Preferred Stock”) that were outstanding during the three and six months ended June 30, 2012, were considered to be participating securities and the two-class method was used for purposes of calculating basic net income per share. Under the two-class method, a portion of net income was allocated to these participating securities and excluded from the calculation of basic net income per common share. On December 21, 2012, all outstanding shares of Preferred Stock were converted into shares of common stock. Diluted net income per common share reflects the effects of potentially dilutive share-based equity instruments and common stock issuable upon conversion of the Preferred Stock.

Share-based awards to purchase 334 and 321 shares of common stock for the three and six months ended June 30, 2013, respectively, were not included in the calculation of diluted net income per common share because the effect of these instruments was anti-dilutive. Share-based awards to purchase 2,265 shares of common stock for the six months ended June 30, 2012, were not included in the calculation of diluted net income per common share because the effect of these instruments was anti-dilutive.

The following table sets forth the computation of basic and diluted net income (loss) per common share for the three and six months ended June 30, 2013 and 2012, respectively:



	Three Months Ended June 30,					Six Months Ended June 30,
	2013		2012			2013		2012
Income (loss) from continuing operations	$	8,399	$	(81	)	$	15,962	$	3,372
Income from discontinued operations, net of tax	—		—			—		823
Net income (loss)	$	8,399	$	(81	)	$	15,962	$	4,195

Less: Allocation to participating securities - from continuing operations	—		—			—		(352		)
Allocation to participating securities - from discontinued operations	—		—			—		(86		)
Total allocation to participating securities	—		—			—		(438		)
Net income (loss) attributable to common stockholders - basic	$	8,399	$	(81	)	15,962		3,757

Basic income (loss) per common share from:
Continuing operations	$	0.18	$	0.00		$	0.35	$	0.07
Discontinued operations	0.00		0.00			0.00		0.02
Net income (loss)	$	0.18	$	0.00		$	0.35	$	0.09
Diluted income (loss) per common share from:
Continuing operations	$	0.18	$	0.00		$	0.33	$	0.07
Discontinued operations	0.00		0.00			0.00		0.02
Net income (loss)	$	0.18	$	0.00		$	0.33	$	0.09

Weighted average common shares outstanding—basic	46,039		40,810			45,927		40,695
Plus dilutive effect of potential common shares	1,798		—			1,832		5,622
Weighted average common shares outstanding—diluted	47,837		40,810			47,759		46,317

Segment Information

6 Months Ended

Jun. 30, 2013

Segment Reporting [Abstract]

SEGMENT INFORMATION

The Company has three reportable segments: nurse and allied healthcare staffing, locum tenens staffing and physician permanent placement services.

The Company’s management relies on internal management reporting processes that provide revenue and operating income by reportable segment for making financial decisions and allocating resources. Segment operating income includes income from continuing operations before depreciation, amortization of intangible assets, share-based compensation expense, interest expense (net) and other unallocated corporate overhead. The Company’s management does not evaluate, manage or measure performance of segments using asset information; accordingly, asset information by segment is not prepared or disclosed.

The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment’s internal financial information as used for corporate management purposes:



	Three Months Ended June 30,					Six Months Ended June 30,
	2013		2012			2013		2012
Revenue
Nurse and allied healthcare staffing	$	170,138	$	158,615		$	346,903	$	312,501
Locum tenens staffing	72,708		67,592			138,164		131,101
Physician permanent placement services	11,097		9,579			20,996		18,596
	$	253,943	$	235,786		$	506,063	$	462,198
Segment Operating Income
Nurse and allied healthcare staffing	$	20,128	$	18,444		$	42,602	$	35,521
Locum tenens staffing	4,908		6,091			9,800		10,507
Physician permanent placement services	2,289		1,890			4,530		3,596
	27,325		26,425			56,932		49,624
Unallocated corporate overhead	5,985		8,179			14,490		13,911
Depreciation and amortization	3,240		3,552			6,530		7,247
Share-based compensation	1,478		1,577			3,180		3,006
Interest expense, net	3,130		13,590			5,989		19,123
Income (loss) from continuing operations before income taxes	$	13,492	$	(473	)	$	26,743	$	6,337

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 131
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Fair Value Measurement

6 Months Ended

Jun. 30, 2013

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENT

The authoritative guidance defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. It also establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:

Level 1—Quoted prices in active markets for identical assets or liabilities.

Level 2—Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

Financial assets and liabilities

The Company utilizes the market approach to measure fair value for its financial assets and liabilities. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. As of June 30, 2013 and December 31, 2012, the Company held certain assets that are required to be measured at fair value on a recurring basis. These included the restricted cash equivalents and investments and the Company’s investments associated with its deferred compensation plan. The Company’s restricted cash equivalents and investments typically consist of U.S. Treasury securities, and the fair value is based on quoted prices in active markets for identical assets. The Company’s investments associated with its deferred compensation plan typically consist of money market funds and mutual funds that are publicly traded and for which market prices are readily available.

Financial assets measured at fair value on a recurring basis are summarized below:



	Fair Value Measurements as of June 30, 2013
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
U.S. Treasury securities	$	17,816	$	17,816	$	—	$	—
Trading securities investment	584		584		—		—
Total financial assets measured at fair value	$	18,400	$	18,400	$	—	$	—



	Fair Value Measurements as of December 31, 2012
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
U.S. Treasury securities	$	18,298	$	18,298	$	—	$	—
Trading securities investment	42		42		—		—
Total financial assets measured at fair value	$	18,340	$	18,340	$	—	$	—

Non-financial assets and liabilities

The Company applies fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to goodwill and indefinite-lived intangible assets accounted for pursuant to accounting guidance on goodwill and other intangible assets.

The Company evaluates goodwill at the reporting unit level and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. The Company determines the fair value of its reporting units based on a combination of inputs including the market capitalization of the Company as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. The Company determined the fair value of its indefinite-lived intangible assets using the income approach (relief-from-royalty method) based on Level 3 inputs.

The Company performed the annual impairment testing at October 31, 2012, and determined there was no impairment of goodwill. No events have occurred subsequent to October 31, 2012 that indicate impairment may have occurred. The Company did not have any significant non-financial assets or liabilities measured at fair value on December 31, 2012 and June 30, 2013.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7578670&loc=d3e19207-110258

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=7491637&loc=d3e13537-108611

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=7491637&loc=d3e13504-108611

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=7491637&loc=d3e13433-108611

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 15B
-Subparagraph a, b
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 133
-Paragraph 44A, 44B
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 159
-Paragraph 17-22, 27, 28
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 15A
-Subparagraph a-d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 15C, 15D
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 157
-Paragraph 32, 33, 34
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 3, 10, 14, 15
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Income Taxes	6 Months Ended
Income Taxes	Jun. 30, 2013
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES The Company currently estimates its annual effective income tax rate will be approximately 39.9% for 2013, as compared to the 40.3% effective income tax rate from continuing operations in 2012. The difference in effective tax rates for 2012 and the forecasted rate for 2013 is primarily due to the relationship of pre-tax income to permanent differences. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which the temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities (including the impact of available carryback and carryforward periods), projected future taxable income, and tax-planning strategies in making this assessment. Significant differences between pre-tax income and taxable income for recent years are related to goodwill impairment and other permanent differences. Based upon the level of historical taxable income and projections for future taxable income over the periods in which the deferred tax assets are deductible, management believes it is more likely than not that the Company will realize the benefits of these deductible differences. The amount of the deferred tax asset considered realizable, however, could be reduced in the near term if estimates of future taxable income during the carryforward period are reduced. The Company is subject to taxation in the U.S. and various states and foreign jurisdictions. With few exceptions, as of June 30, 2013, the Company is no longer subject to U.S. federal, state, local or foreign examinations by tax authorities for years before 2005. The Internal Revenue Service ("IRS") has issued a Revenue Agent Report (RAR) to the Company related to its recently completed tax examination. The RAR seeks adjustments to the Company's taxable income for 2007-2010 and net operating loss carryforwards from 2005-2006. The adjustments to the Company's taxable income relate to the proposed disallowance of certain per diems paid to our clinicians and locum tenens providers on the Company's income tax return. Concurrent with the RAR, the Company received an Employment Tax Examination Report (ETER) for 2009 and 2010. The ETER adjustments propose additional Company payroll tax liabilities related to the treatment of certain non-taxable per diem allowances and travel benefits. The positions in the RAR and ETER are mutually exclusive. The RAR and ETER contain multiple tax positions, some of which are contrary to each other and thus the Company is unable to determine any reasonable range of potential claim at this time. The Company has filed a Protest Letter for both the RAR and ETER and intends to defend its position. The Company does not expect resolution of this matter within twelve months and cannot predict with certainty the timing of such resolution. The Company believes its reserve for unrecognized tax benefits and contingent tax issues is adequate. Notwithstanding, the Company could adjust its provision for income taxes and or contingent tax liability based on future developments.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 109
-Paragraph 136, 172
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph h
-Article 4

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 109
-Paragraph 43, 44, 45, 46, 47, 48, 49
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Notes Payable and Related Credit Agreement

6 Months Ended

Jun. 30, 2013

Debt Disclosure [Abstract]

NOTES PAYABLE AND RELATED CREDIT AGREEMENT

In April 2012, the Company entered into a Credit Agreement that provides two credit facilities (the “Credit Facilities”), including (A) a $50,000 revolving credit facility (the “Revolver”) and (B) a $200,000 face value secured term loan credit facility, net of unamortized original issue discount of $2,000 (the “Term Loan”). The Company entered into the First Amendment to the Credit Agreement (the “First Amendment”) with the lenders under the Credit Facilities, which went into effect on April 9, 2013.

Among other things, the First Amendment amends the Credit Agreement as follows:

•

Reduction in the Interest Rate on the Revolver. Under the original Credit Agreement, borrowings under the Revolver bore interest at floating rates based upon either a LIBOR or a base rate option selected by the Company, plus a spread (the “LIBOR Loan Spread”) of 3.75% to 4.25% and a spread (the “Base Rate Loan Spread”) of 2.75% to 3.25%, respectively, in each case, as specifically determined quarterly based upon the Company’s then-existing consolidated leverage ratio (as defined in the Credit Agreement). The First Amendment reduces each of the Revolver LIBOR Loan Spread and the Revolver Base Rate Loan Spread by 150 basis points, to 2.25% to 2.75% and 1.25% to 1.75%, respectively.

•

Reduction in the Interest Rate on the Term Loan. Under the original Credit Agreement, borrowings under the Term Loan bore interest at floating rates based upon either a LIBOR (with a floor of 1.25%) or a base rate option selected by the Company, plus a LIBOR Loan Spread of 4.50% to 4.75% and a Base Rate Loan Spread of 3.50% to 3.75%, respectively, in each case, as specifically determined quarterly based upon the Company’s then-existing consolidated leverage ratio. The First Amendment reduces each of the Term Loan LIBOR Loan Spread and the Term Loan Base Rate Loan Spread by 150 to 175 basis points (depending on the original Credit Agreement Consolidated Leverage Ratio step) to 3.00% and 2.00%, respectively. It also reduces the LIBOR floor by 50 basis points, from 1.25% to 0.75%.


•	Increased Sublimit for the Issuance of Letter of Credit. The original Credit Agreement provided for a $20,000 sublimit for the issuance of letters of credit under the Revolver. The First Amendment increases the sublimit to $30,000.

In connection with the First Amendment, the Company incurred $935 in deferred financing fees, of which $364 were capitalized and are amortized to interest expense over the remaining term of the Credit Agreement and the remaining amount was recorded as interest expense in April 2013. In addition, in April 2013, the Company wrote off to interest expense $434 of unamortized deferred financing fees and original issue discount resulting from the First Amendment.

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References + Details

Commitments and Contingencies: Legal	6 Months Ended
Commitments and Contingencies: Legal	Jun. 30, 2013
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES: LEGAL	COMMITMENTS AND CONTINGENCIES: LEGAL The Company is subject to various claims and legal actions in the ordinary course of its business. Some of these matters relate to professional liability, tax, payroll, contract and employee-related matters and include individual and collective lawsuits, as well as inquiries and investigations by governmental agencies regarding the Company’s employment practices. The most significant matter of which the Company is currently the defendant is a class action related to wage and hour claims. In the second quarter of 2013, the Company reached a settlement with the plaintiffs in such action (and a related action) for an immaterial amount, which settlement is subject to the approval of the Court. At June 30, 2013, the Company had fully reserved for the settlement of such action, which was included in accounts payable and accrued expenses in the unaudited condensed consolidated balance sheet at June 30, 2013, a majority of which had been accrued in prior periods. Additionally, some of the Company’s clients may also become subject to claims, governmental inquiries and investigations and legal actions relating to services provided by the Company’s clinicians and physicians. From time to time, and depending upon the particular facts and circumstances, the Company may be subject to indemnification obligations under its contracts with such clients relating to these matters.

- Definition

The entire disclosure for commitments and contingencies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14435-108349

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 14
-Paragraph 3
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 5
-Paragraph 9, 10, 11, 12
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Treasury Stock	6 Months Ended
Treasury Stock	Jun. 30, 2013
Treasury Stock Transactions, Excluding Value of Shares Reissued [Abstract]
TREASURY STOCK	TREASURY STOCK In connection with the 2010 acquisition of NF Investors, Inc., a Delaware corporation ("NFI"), the parent company of Medfinders, 457 shares of the Company's common stock remained in escrow as of December 31, 2012 for potential Company indemnification claims. During the second quarter of 2013, the Company and former NFI selling shareholders agreed to release all 457 shares in escrow as follows: 1) 204 shares were returned to the Company for settlement of certain indemnification claims, which have been recorded as a $3,046 benefit offsetting selling, general and administrative expenses for the three and six months ended June 30, 2013 and classified as treasury stock on the unaudited condensed consolidated balance sheet at June 30, 2013; and 2) the remaining 253 shares were released from escrow to the former NFI selling shareholders.

Basis of Presentation (Policies)	6 Months Ended
Basis of Presentation (Policies)	Jun. 30, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Recently Adopted Accounting Pronouncements	In July 2012, the Financial Accounting Standards Board issued an accounting standard update intended to simplify how an entity tests indefinite-lived intangible assets other than goodwill for impairment by providing entities with an option to perform a qualitative assessment to determine whether further impairment testing is necessary. This accounting standard update is effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012. The Company adopted this guidance effective January 1, 2013 and such adoption did not have a material effect on its unaudited condensed consolidated financial statements.

Discontinued Operations (Tables)

6 Months Ended

Jun. 30, 2013

Discontinued Operations and Disposal Groups [Abstract]

Components of discontinued operations, net of tax

The following table represents the revenue and the components of discontinued operations, net of tax:



	Six months ended June 30, 2012
Revenue	$	3,885

Loss before income taxes	(547		)
Income tax benefit	183
Loss from discontinued operations	(364		)

Gain on sale of discontinued operations, before income taxes	3,825
Income tax expense	(2,638		)
Gain on sale of discontinued operations	1,187

Total income from discontinued operations	$	823

- Definition

Tabular disclosure of disposal groups, which may include the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and pretax profit or loss reported in discontinued operations, the classification and carrying value of the assets and liabilities comprising the disposal group, and the segment in which the disposal group was reported. Also may include the amount of adjustments to amounts previously reported in discontinued operations such as resolution of contingencies arising from the disposal transaction or the operations of the component prior to disposal.

+ References + Details

Net Income (Loss) Per Common Share (Tables)

6 Months Ended

Jun. 30, 2013

Earnings Per Share [Abstract]

Computation of basic and diluted net income (loss) per common share

The following table sets forth the computation of basic and diluted net income (loss) per common share for the three and six months ended June 30, 2013 and 2012, respectively:



	Three Months Ended June 30,					Six Months Ended June 30,
	2013		2012			2013		2012
Income (loss) from continuing operations	$	8,399	$	(81	)	$	15,962	$	3,372
Income from discontinued operations, net of tax	—		—			—		823
Net income (loss)	$	8,399	$	(81	)	$	15,962	$	4,195

Less: Allocation to participating securities - from continuing operations	—		—			—		(352		)
Allocation to participating securities - from discontinued operations	—		—			—		(86		)
Total allocation to participating securities	—		—			—		(438		)
Net income (loss) attributable to common stockholders - basic	$	8,399	$	(81	)	15,962		3,757

Basic income (loss) per common share from:
Continuing operations	$	0.18	$	0.00		$	0.35	$	0.07
Discontinued operations	0.00		0.00			0.00		0.02
Net income (loss)	$	0.18	$	0.00		$	0.35	$	0.09
Diluted income (loss) per common share from:
Continuing operations	$	0.18	$	0.00		$	0.33	$	0.07
Discontinued operations	0.00		0.00			0.00		0.02
Net income (loss)	$	0.18	$	0.00		$	0.33	$	0.09

Weighted average common shares outstanding—basic	46,039		40,810			45,927		40,695
Plus dilutive effect of potential common shares	1,798		—			1,832		5,622
Weighted average common shares outstanding—diluted	47,837		40,810			47,759		46,317

Segment Information (Tables)

6 Months Ended

Jun. 30, 2013

Segment Reporting [Abstract]

Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results



	Three Months Ended June 30,					Six Months Ended June 30,
	2013		2012			2013		2012
Revenue
Nurse and allied healthcare staffing	$	170,138	$	158,615		$	346,903	$	312,501
Locum tenens staffing	72,708		67,592			138,164		131,101
Physician permanent placement services	11,097		9,579			20,996		18,596
	$	253,943	$	235,786		$	506,063	$	462,198
Segment Operating Income
Nurse and allied healthcare staffing	$	20,128	$	18,444		$	42,602	$	35,521
Locum tenens staffing	4,908		6,091			9,800		10,507
Physician permanent placement services	2,289		1,890			4,530		3,596
	27,325		26,425			56,932		49,624
Unallocated corporate overhead	5,985		8,179			14,490		13,911
Depreciation and amortization	3,240		3,552			6,530		7,247
Share-based compensation	1,478		1,577			3,180		3,006
Interest expense, net	3,130		13,590			5,989		19,123
Income (loss) from continuing operations before income taxes	$	13,492	$	(473	)	$	26,743	$	6,337

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References + Details

Fair Value Measurement (Tables)

6 Months Ended

Jun. 30, 2013

Fair Value Disclosures [Abstract]

Schedule of financial assets and liabilities measured at fair value on recurring basis

Financial assets measured at fair value on a recurring basis are summarized below:



	Fair Value Measurements as of June 30, 2013
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
U.S. Treasury securities	$	17,816	$	17,816	$	—	$	—
Trading securities investment	584		584		—		—
Total financial assets measured at fair value	$	18,400	$	18,400	$	—	$	—



	Fair Value Measurements as of December 31, 2012
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
U.S. Treasury securities	$	18,298	$	18,298	$	—	$	—
Trading securities investment	42		42		—		—
Total financial assets measured at fair value	$	18,340	$	18,340	$	—	$	—

Discontinued Operations (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
Discontinued Operations (Details) - USD ($) $ in Thousands	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Components of discontinued operations, net of tax
Gain on sale of discontinued operations			$ 0	$ 1,187
Total income from discontinued operations	$ 0	$ 0	$ 0	823
Healthcare services segment [Member]
Components of discontinued operations, net of tax
Revenue				3,885
Loss before income taxes				(547)
Income tax benefit				183
Loss from discontinued operations				(364)
Gain on sale of discontinued operations, before income taxes				3,825
Income tax expense				(2,638)
Gain on sale of discontinued operations				1,187
Total income from discontinued operations				$ 823

Revenue Recognition (Details) - USD ($) $ in Thousands	Jun. 30, 2013	Dec. 31, 2012
Revenue Recognition [Abstract]
Accounts Payable to Subcontractor	$ 14,909	$ 18,129

Net Income (Loss) Per Common Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Earnings Per Share [Abstract]
Common stock excluded from calculation of EPS	334		321	2,265
Computation of basic and diluted net income (loss) per common share
Income (loss) from continuing operations	$ 8,399	$ (81)	$ 15,962	$ 3,372
Income from discontinued operations, net of tax	0	0	0	823
Net income (loss)	8,399	(81)	15,962	4,195
Less: Allocation to participating securities - from continuing operations	0	0	0	(352)
Allocation to participating securities - from discontinued operations	0	0	0	(86)
Total allocation to participating securities	0	0	0	(438)
Net income (loss) attributable to common stockholders - basic	$ 8,399	$ (81)	$ 15,962	$ 3,757
Basic income (loss) per common share from:
Continuing operations (in dollars per share)	$ 0.18	$ 0.00	$ 0.35	$ 0.07
Discontinued operations (in dollars per share)	0.00	0.00	0.00	0.02
Net income (in dollars per share)	0.18	0.00	0.35	0.09
Diluted income (loss) per common share from:
Continuing operations (in dollars per share)	0.18	0.00	0.33	0.07
Discontinued operations (in dollars per share)	0.00	0.00	0.00	0.02
Net income (in dollars per share)	$ 0.18	$ 0.00	$ 0.33	$ 0.09
Weighted average common shares outstanding—basic	46,039	40,810	45,927	40,695
Plus dilutive effect of potential common shares	1,798	0	1,832	5,622
Weighted average common shares outstanding—diluted	47,837	40,810	47,759	46,317

Segment Information (Details) $ in Thousands	3 Months Ended		6 Months Ended
Segment Information (Details) $ in Thousands	Jun. 30, 2013 USD ($)	Jun. 30, 2012 USD ($)	Jun. 30, 2013 USD ($) segment	Jun. 30, 2012 USD ($)
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results
Revenue	$ 253,943	$ 235,786	$ 506,063	$ 462,198
Segment Operating Income	27,325	26,425	56,932	49,624
Unallocated corporate overhead	5,985	8,179	14,490	13,911
Depreciation and amortization	3,240	3,552	6,530	7,247
Share-based compensation	1,478	1,577	3,180	3,006
Interest expense, net	3,130	13,590	5,989	19,123
Income (loss) from continuing operations before income taxes	13,492	(473)	$ 26,743	6,337
Segment Information (Textual) [Abstract]
Reportable business segments \| segment			3
Nurse and allied healthcare staffing [Member]
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results
Revenue	170,138	158,615	$ 346,903	312,501
Segment Operating Income	20,128	18,444	42,602	35,521
Locum tenens staffing [Member]
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results
Revenue	72,708	67,592	138,164	131,101
Segment Operating Income	4,908	6,091	9,800	10,507
Physician permanent placement services [Member]
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results
Revenue	11,097	9,579	20,996	18,596
Segment Operating Income	$ 2,289	$ 1,890	$ 4,530	$ 3,596

Fair Value Measurement - Financial Assets and Liabilities (Details) - USD ($)	Oct. 31, 2012	Jun. 30, 2013	Dec. 31, 2012
Schedule of financial assets and liabilities measured at fair value on recurring basis
Total financial assets measured at fair value		$ 18,400,000	$ 18,340,000
Impairment charges	$ 0
US Treasury securities [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Total financial assets measured at fair value		17,816,000	18,298,000
Trading securities investment [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Total financial assets measured at fair value		584,000	42,000
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Total financial assets measured at fair value		18,400,000	18,340,000
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] \| US Treasury securities [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Total financial assets measured at fair value		17,816,000	18,298,000
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] \| Trading securities investment [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Total financial assets measured at fair value		584,000	42,000
Significant Other Observable Inputs (Level 2) [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Total financial assets measured at fair value		0	0
Significant Other Observable Inputs (Level 2) [Member] \| US Treasury securities [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Total financial assets measured at fair value		0	0
Significant Other Observable Inputs (Level 2) [Member] \| Trading securities investment [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Total financial assets measured at fair value		0	0
Significant Unobservable Inputs (Level 3) [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Total financial assets measured at fair value		0	0
Significant Unobservable Inputs (Level 3) [Member] \| US Treasury securities [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Total financial assets measured at fair value		0	0
Significant Unobservable Inputs (Level 3) [Member] \| Trading securities investment [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Total financial assets measured at fair value		$ 0	$ 0

- Definition

Loss recognized during the period that results from the write-down of goodwill after comparing the implied fair value of reporting unit goodwill with the carrying amount of that goodwill. Goodwill is assessed at least annually for impairment.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=14024403&loc=d3e13854-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13777-109266

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=14024403&loc=d3e13816-109267

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 72
-Subparagraph d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 142
-Paragraph 43
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 142
-Paragraph 20
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 142
-Paragraph 45
-Subparagraph e
-Clause 5
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 142
-Paragraph 47
-Subparagraph b
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Income Taxes Income Taxes (Details)	6 Months Ended
Income Taxes Income Taxes (Details)	Jun. 30, 2013	Jun. 30, 2012
Income Tax Disclosure [Abstract]
Estimated annual effective income tax rate	39.90%
Effective income tax rate		40.30%

Notes Payable and Related Credit Agreement (Details)		1 Months Ended
Notes Payable and Related Credit Agreement (Details)	Apr. 09, 2013 USD ($)	Apr. 30, 2012 USD ($) credit_facility	Jun. 30, 2013
Line of Credit Facility [Line Items]
Number of credit facilities \| credit_facility		2
Deferred finance costs incurred	$ 935,000
Amount of deferred financing costs to be capitalized and amortized	364,000
Amount of unamortized deferred financing costs and discounts to be written off	$ 434,000
Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Credit facility, available		$ 50,000,000
Reduction in basis points	1.50%
Notes Payable to Banks [Member]
Line of Credit Facility [Line Items]
Credit facility, available		200,000,000
Net of unamortized original issue discount		$ 2,000,000
Floor interest rates spread over borrowings under term loan	0.75%	1.25%
Reduction in LIBOR floor	0.50%
Letter of Credit [Member]
Line of Credit Facility [Line Items]
Sublimit for swingline loans	$ 30,000,000	$ 20,000,000
Minimum [Member] \| Notes Payable to Banks [Member]
Line of Credit Facility [Line Items]
Reduction in basis points	1.50%
Maximum [Member] \| Notes Payable to Banks [Member]
Line of Credit Facility [Line Items]
Reduction in basis points	1.75%
London Interbank Offered Rate (LIBOR) [Member] \| Notes Payable to Banks [Member]
Line of Credit Facility [Line Items]
Interest rates spread over LIBOR rate	3.00%
London Interbank Offered Rate (LIBOR) [Member] \| Minimum [Member] \| Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Interest rates spread over LIBOR rate	2.25%		3.75%
London Interbank Offered Rate (LIBOR) [Member] \| Minimum [Member] \| Notes Payable to Banks [Member]
Line of Credit Facility [Line Items]
Interest rates spread over LIBOR rate			4.50%
London Interbank Offered Rate (LIBOR) [Member] \| Maximum [Member] \| Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Interest rates spread over LIBOR rate	2.75%		4.25%
London Interbank Offered Rate (LIBOR) [Member] \| Maximum [Member] \| Notes Payable to Banks [Member]
Line of Credit Facility [Line Items]
Interest rates spread over LIBOR rate			4.75%
Base Rate [Member] \| Notes Payable to Banks [Member]
Line of Credit Facility [Line Items]
Interest rates spread over LIBOR rate	2.00%
Base Rate [Member] \| Minimum [Member] \| Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Interest rates spread over LIBOR rate	1.25%		2.75%
Base Rate [Member] \| Minimum [Member] \| Notes Payable to Banks [Member]
Line of Credit Facility [Line Items]
Interest rates spread over LIBOR rate			3.50%
Base Rate [Member] \| Maximum [Member] \| Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Interest rates spread over LIBOR rate	1.75%		3.25%
Base Rate [Member] \| Maximum [Member] \| Notes Payable to Banks [Member]
Line of Credit Facility [Line Items]
Interest rates spread over LIBOR rate			3.75%

Treasury Stock (Details) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2013	Jun. 30, 2012	Dec. 31, 2012
Treasury Stock Transactions, Excluding Value of Shares Reissued [Abstract]
Stock In Escrow For Indemnification Claims				457
Common Stock Released From Escrow	457	457
Treasury stock, shares	204	204		0
Common Stock Returned to Former Acquired Company's Selling Shareholders	253	253
Holdback settlement in equity from prior acquisition	$ 3,046	$ 3,046	$ 0